Compare Abeona Therapeutics Inc (ABEO) vs VanEck JP Morgan EM Local Currency Bond ETF (EMLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs VanEck JP Morgan EM Local Currency Bond ETF — how do they compare? Abeona Therapeutics Inc trades at $7.34 (market cap $421.19M), while VanEck JP Morgan EM Local Currency Bond ETF trades at $25.65. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, VanEck JP Morgan EM Local Currency Bond ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | EMLC | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Fixed Income |
52-Week High | $7.45 | $26.59 |
52-Week Low | $4.17 | $24.83 |
Enterprise Value | $276.10M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $7.365, down 1.14% today, amid a bullish technical outlook with moving averages signaling strength. The company reported a net income of $71.18 million in 2025, with a net margin of 454.86%, though revenue remains modest at $5.82 million. Recent news includes CMS granting NTAP status for ZEVASKYN and expanding its treatment center network, indicating commercial progress.
The outlook is supported by strong analyst consensus (66.7% buy ratings) and robust profitability metrics, but risks include high SG&A expenses relative to revenue and a shareholder investigation. Upside hinges on revenue scaling to justify current valuations, with the Q2 2026 earnings call on August 13, 2026, as a key near-term catalyst.
EMLC trades at $25.655, up 0.14% with a bullish technical signal from moving averages and neutral oscillators. The stock shows consistent dividend distributions, with recent payouts of $0.14 in June 2026. Support and resistance cluster around $26, indicating a key price level. Financial ratios are not provided in the snapshot, limiting fundamental assessment.
Outlook hinges on emerging market debt dynamics and Federal Reserve policy, as noted in recent news. Risks include volatility from macroeconomic shifts and regional instability. The technical setup suggests near-term stability, but fundamental clarity is needed for long-term confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About VanEck JP Morgan EM Local Currency Bond ETF
EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →
